Bayer enlists Curadev in STING antagonist collaboration
STING is known to play a role in activating the innate immune system in auto-inflammatory diseases.
Read More
Author: Anna Smith
Hep C cases down around 70% in HIV positive men in London and Brighton
Regular hepatitis C screening and improved access to new treatments has potentially contributed to greatly reducing the transmission of the infection.
Read More
COVID-19: AstraZeneca to distribute masks as ASCO goes virtual
PHE has also been awarded $500,000 by the US FDA to bolster the international response.
Read More
AZ to develop siRNA with Silence Theraputics
siRNA are double-stranded RNA molecules that offer new opportunities for therapeutic intervention because they act inside the cell to influence protein production.
Read More
Venclexta/Venclyxto combo extends myeloid leukaemia survival
Roche also reported that safety for Venclexta/Venclyxto with azacitidine appeared consistent with the known safety profile of these medicines.
Read More- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
